BOSTON, MASSACHUSETTS

February 22–25, 2016

CROI 2016: Boston

The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses. CROI 2016 will be held from February 22 to February 25, 2016, in Boston, Massachusetts, at the Hynes Convention Center. Webcasts, abstracts, electronic posters, and other electronic resources from CROI 2016 will be available online via webcast.

The CROI Foundation partners with the International Antiviral Society–USA (IAS–USA) for organization of the conference.

General registration is officially closed. However, if you still wish to register, your application will be put on the waiting list. For more information, go to Registration and Housing.

Travel Advisory: Due to increased security, CROI attendees are encouraged to have travel documents in order (including a visa if required) well in advance of their departure date for the meeting.

In Memoriam and Tribute to Dr Suniti Solomon.

What's New

January 29, 2016

General registration is officially closed. However, if you still wish to register, your application will be put on the waiting list. For more information, go to Registration and Housing.

January 25, 2016

Tomorrow, January 26, is the last day to apply to register for the CROI 2016. For more information, go to Registration and Housing.

January 19, 2016

The submission period for late-breaking abstracts is now CLOSED. Late-breaking abstract dispositions were e-mailed. If you are a presenting author, or poster presenter, you will receive an e-mail that includes the final abstract number and session information in the weeks leading up to the conference.